NCT03384420View on ClinicalTrials.gov

A Study to Evaluate the Safety and Therapeutic Effects of Transplantation of MNV-BM-BLD in Pediatric Patients With Pearson Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

February 13, 2019

Primary Completion Date

March 9, 2021

Study Completion Date

March 9, 2021

Conditions
Mitochondrial DiseasesPearson Syndrome
Interventions
BIOLOGICAL

CD34+ cells enriched with MNV-BLD

Transplantation of autologous stem cell enriched with MNV-BLD (blood-derived mitochondria)

Trial Locations (1)

Unknown

Sheba Medical Center Hospital- Tel Hashomer, Ramat Gan

Sponsors
All Listed Sponsors
lead

Minovia Therapeutics Ltd.

INDUSTRY

NCT03384420 - A Study to Evaluate the Safety and Therapeutic Effects of Transplantation of MNV-BM-BLD in Pediatric Patients With Pearson Syndrome | Biotech Hunter | Biotech Hunter